Fusen Pharmaceutical Company Limited (HKG:1652)

HKG:1652 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.06	34.85	128.11	81.06	297.04
Short-Term Investments	-	-	-	0.64	-
Trading Asset Securities	-	-	-	-	15.49
Cash & Short-Term Investments	21.06	34.85	128.11	81.71	312.53
Cash Growth	-39.58%	-72.80%	56.79%	-73.86%	-5.59%
Accounts Receivable	113.88	183.48	247.19	157.58	183.93
Other Receivables	145.39	114.15	66.85	103.61	56.41
Receivables	259.27	297.63	314.04	261.19	240.34
Inventory	153.35	184.2	123.49	128.97	107.5
Prepaid Expenses	8.56	5.49	-	-	-
Other Current Assets	17.39	44.63	48.43	37.35	-
Total Current Assets	459.61	566.8	614.06	509.22	660.37
Property, Plant & Equipment	621.33	562.18	529.75	506.03	485.93
Long-Term Investments	43.88	148.97	178.31	198.06	67.65
Other Intangible Assets	28.14	22.55	0.48	0.68	0.88
Long-Term Deferred Tax Assets	6.64	5.02	5.08	5.63	5.71
Other Long-Term Assets	78.57	38.22	22.6	19.7	20.81
Total Assets	1,238	1,344	1,350	1,239	1,241
Accounts Payable	123.47	167.55	163.61	102.12	108.59
Accrued Expenses	160.84	147.32	157.57	143.76	164.73
Short-Term Debt	4.61	4.61	230.45	150.52	178.5
Current Portion of Long-Term Debt	303.54	236.56	-	20	-
Current Portion of Leases	0.92	1.09	2.11	1.83	-
Current Income Taxes Payable	5.51	6.09	7.15	-	1.67
Current Unearned Revenue	8.94	3.9	67.55	4.62	13.58
Other Current Liabilities	164.63	97.43	93.65	66.42	80.54
Total Current Liabilities	772.45	664.52	722.08	489.27	547.61
Long-Term Debt	79.1	105.7	-	76	20
Long-Term Leases	0.13	0.77	0.43	1.94	-
Long-Term Unearned Revenue	18.12	10.23	11.32	10.51	8.36
Long-Term Deferred Tax Liabilities	-	0.3	3.54	4.68	7.13
Total Liabilities	869.8	781.52	737.38	582.39	583.1
Common Stock	6.18	6.31	6.38	6.48	6.51
Additional Paid-In Capital	224.23	230.78	246.73	259.46	274.78
Retained Earnings	103.82	292.61	328.88	363.49	346.84
Treasury Stock	-	-0.08	-0.05	-0.04	-0.03
Comprehensive Income & Other	35.44	33.91	32.22	28.79	31.33
Total Common Equity	369.67	563.52	614.17	658.17	659.44
Minority Interest	-1.31	-1.29	-1.27	-1.23	-1.19
Shareholders' Equity	368.36	562.23	612.89	656.94	658.25
Total Liabilities & Equity	1,238	1,344	1,350	1,239	1,241
Total Debt	388.3	348.72	232.99	250.29	198.5
Net Cash (Debt)	-367.24	-313.87	-104.88	-168.59	114.03
Net Cash Growth	-	-	-	-	-5.80%
Net Cash Per Share	-0.50	-0.42	-0.14	-0.22	0.14
Filing Date Shares Outstanding	739.3	745.04	758.21	764.82	770.43
Total Common Shares Outstanding	739.3	745.04	758.21	764.82	770.43
Working Capital	-312.83	-97.72	-108.03	19.96	112.76
Book Value Per Share	0.50	0.76	0.81	0.86	0.86
Tangible Book Value	341.54	540.97	613.68	657.49	658.56
Tangible Book Value Per Share	0.46	0.73	0.81	0.86	0.85
Buildings	294.82	278.2	278.02	220.23	152.95
Machinery	234.79	204.33	144.85	142.73	100.05
Construction In Progress	21.93	3.46	0.58	4.79	124.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.